410 related articles for article (PubMed ID: 28369830)
1. Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
Oura T; Cosimi AB; Kawai T
Clin Exp Immunol; 2017 Aug; 189(2):190-196. PubMed ID: 28369830
[TBL] [Abstract][Full Text] [Related]
2. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
3. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
Leventhal JR; Ildstad ST
Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.
Sasaki H; Oura T; Spitzer TR; Chen YB; Madsen JC; Allan J; Sachs DH; Cosimi AB; Kawai T
Hum Immunol; 2018 May; 79(5):258-265. PubMed ID: 29175110
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
7. Tolerance induction: hematopoietic chimerism.
Kawai T; Sachs DH
Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
[TBL] [Abstract][Full Text] [Related]
8. [Transplant tolerance through mixed chimerism].
Zuber J
Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
[TBL] [Abstract][Full Text] [Related]
9. Hurdles to the induction of tolerogenic mixed chimerism.
Pilat N; Klaus C; Schwaiger E; Wekerle T
Transplantation; 2009 May; 87(9 Suppl):S79-84. PubMed ID: 19424016
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance.
Granados JM; Benichou G; Kawai T
Curr Opin Organ Transplant; 2015 Feb; 20(1):49-56. PubMed ID: 25563992
[TBL] [Abstract][Full Text] [Related]
11. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
Podestà MA; Sykes M
Front Immunol; 2021; 12():791725. PubMed ID: 35069574
[TBL] [Abstract][Full Text] [Related]
12. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials for renal allograft tolerance induction through combined hematopoietic stem cell transplantation: A narrative review.
Hotta K; Hirose T; Kawai T
Int J Urol; 2022 Dec; 29(12):1397-1404. PubMed ID: 36101964
[TBL] [Abstract][Full Text] [Related]
14. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.
Kawai T; Cosimi AB; Sachs DH
Curr Opin Organ Transplant; 2011 Aug; 16(4):366-71. PubMed ID: 21666482
[TBL] [Abstract][Full Text] [Related]
17. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
18. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
[TBL] [Abstract][Full Text] [Related]
19. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
20. Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning.
Nusair S; Gincberg G; Almogi-Hazan O; Breuer R; Or R; Wallach-Dayan SB
Transpl Immunol; 2012 Dec; 27(4):184-8. PubMed ID: 22801052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]